Skip to content

Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep

Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep. A Randomized Single-blinded Cross-over Study

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03904303
Enrollment
16
Registered
2019-04-05
Start date
2019-06-01
Completion date
2020-12-31
Last updated
2019-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmacological Action

Brief summary

Crossover study comparing Moviprep (for bowel cleansing) with a new gel-based colon cleansing agent before colonoscopy

Detailed description

Crossover study comparing Moviprep (for bowel cleansing) with a new gel-based colon cleansing agent before colonoscopy. Study performed in health subjects.

Interventions

DRUGA 06 ad

Colonic cleansing before colonoscopy and CT colonografi

Sponsors

University of Copenhagen
CollaboratorOTHER
Zealand University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

\- Healthy

Exclusion criteria

* Allergy to content of products

Design outcomes

Primary

MeasureTime frameDescription
Boston Bowel preparation scale (BBPscale)Performed during the endoscopy procedureVisual assessment of the degree of bowel cleansing performed by the endoscopist (blinded). Right colon, colon transversum, and left colon are each judged on a scale from 0-3 with higher scores indicating better cleansing. Range of score between 0-9.
Adverse events related to interventionAssessed 4 hours after last intake of cleansing productAny adverse event related to the intervention observed by investigators or as reported by the participant

Secondary

MeasureTime frameDescription
Blood pressureMeasured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examinationmmHg systolic and diastolic measured on right or left arm.
SaturationMeasured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examinationOxymeter measuring the saturation of hemoglobin with oxygen as a percentage of 0-100%.
Heart rateMeasured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examinationHeart rate
Respiration frequencyMeasured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examinationRespiration frequency

Countries

Denmark

Contacts

Primary ContactHanne Holm, RN
hanh@regionsjaelland.dk+4593567014
Backup ContactSvend Knuhtsen, MD
svkn@regionsjaelland.dk+4523348555

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026